oa South African Family Practice - Medifile : Atomoxetine and Ezetimibe

Volume 48, Issue 1
  • ISSN : 2078-6190
  • E-ISSN: 2078-6204



Extracted from text ... Jan/Feb 2006; 20(1) SA Fam Pract 2006;48(1) 60 u ABSTRACT The first edition of Medifile for 2006 provides information on two new drug classes, Atomoxetine and Ezetimibe. Strattera(r) (Atomoxetine) is the first non-stimulant drug registered for the management of Attention Deficit Hyperactivity Disorder (ADHD). Ezetrol(r) (Ezetimibe) is an anti-hyperlipidaemic and selective cholesterol absorption inhibitor. The selective cholesterol absorption inhibitors are the first new class of cholesterol lowering drugs in 15 years. Both products were launched in South Africa in 2005. u NEW TREATMENT AVAILABLE FOR ADHD: ATOMOXETINE INTRODUCTION Attention deficit hyperactivity disorder (ADHD) occurs in 3- 10% of children.1 ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error